NCT05492682
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT05492682
Title START: Safety and Anti-Tumor Activity of PeptiCRAd-1 in Treatment of Cancer
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Valo Therapeutics Oy
Indications
Therapies
Age Groups: adult | senior
Covered Countries ITA | DEU

Facility Status City State Zip Country Details
Krankenhaus Nordwest ACTIVE_NOT_RECRUITING Frankfurt Germany Details
National Center for Tumor Diseases COMPLETED Heidelberg Germany Details
Universitätsklinikum Tübingen COMPLETED Tübingen Germany Details
Istituto di Candiolo Fondazione del Piemonte per l'oncologia IRCCS RECRUITING Candiolo Italy Details
IRCCS Istituto Clinico Humanitas NOT_YET_RECRUITING Milan Italy Details
IRCCS Ospedale San Raffaele NOT_YET_RECRUITING Milan Italy Details
Università di Napoli Federico II NOT_YET_RECRUITING Naples Italy Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field